EBITDA

With its strategic pivot to high-growth Med Tech paying off, all eyes are on AngioDynamics' CEO presentation at the upcoming Leerink healthcare conference.

The environmental services giant surpassed 2025 targets, driven by its GreenUp strategy, major acquisitions in water tech, and a renewed global push.

Despite weak demand, the chemical giant posts strong cash flow and unveils a new segmentation to highlight its high-value specialty materials business.

Huawei's new AI Calling solution promises real-time translation and smart assistants, but can global networks and privacy standards keep up with innovation?

ASUS unveils new liquid-cooling solutions and a partner ecosystem to combat the intense heat of next-gen AI, promising a more sustainable, powerful future.

Fujitsu's 1Finity launches its L1000/L2000 platform, promising to power AI's data demands with an open, cost-cutting optical network architecture.

The therapy giant reports robust revenue growth and record patient visits, backed by major acquisitions and new 10-year hospital system alliances.

Engineering giant Stantec reports a landmark year with $6.5B revenue, hitting strategic targets early, and raises its dividend, signaling strong future growth.

With a record $411M backlog and surging revenue, Redwire's strategic pivot to defense and space comes at a high cost. Can it turn growth into profit?

The real estate giant announced a take-private merger led by its CEO alongside results showing major growth from its Toll Brothers platform acquisition.

The insurance distributor posted stellar 2025 results, announcing a massive share buyback and new acquisitions to fuel its aggressive growth strategy.

After a year focused on organic growth, the environmental firm posted record results and now plans a disciplined return to acquisitions in 2026.

PROCEPT BioRobotics reports record Aquablation procedures but lowers 2026 revenue guidance, signaling a strategic shift for long-term profitability.

TaskUs announces a major refinancing and a $333M special dividend, all while navigating the dual impact of AI as both a growth engine and a headwind.

Asbury Automotive nets $210M from strategic dealership sales, funneling capital into debt reduction and a massively expanded share repurchase program.

The biopharma company shatters records with 51% growth in its key drug, ASCENIV, and outlines a strategic overhaul aimed at long-term market dominance.

With broadband subscribers declining and competition mounting, all eyes are on Co-CEO Mike Cavanagh to outline Comcast's strategy at a key TMT conference.

The ad-tech giant posted record revenue for 2025, but a weaker-than-expected forecast for early 2026 sent its stock tumbling. What's next?

MiMedx reports record 2025 sales and a $100M buyback, but faces a major challenge from new Medicare reimbursement rules set to disrupt the wound care market.

Amid record financials and new AI breakthroughs, Cadence's CEO will address investors at a key conference to outline the firm's pivotal role in the AI era.